Brent Hatzis-schoch - Net Worth and Insider Trading
Brent Hatzis-schoch Net Worth
The estimated net worth of Brent Hatzis-schoch is at least $101,183 dollars as of 2024-11-13. Brent Hatzis-schoch is the Sr. VP, General Counsel of Radius Health Inc and owns about 2,278 shares of Radius Health Inc (RDUS) stock worth over $73,967. Brent Hatzis-schoch is also the See Remarks of Black Diamond Therapeutics Inc and owns about 8,400 shares of Black Diamond Therapeutics Inc (BDTX) stock worth over $27,216. Details can be seen in Brent Hatzis-schoch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brent Hatzis-schoch has not made any transactions after 2021-05-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brent Hatzis-schoch
Brent Hatzis-schoch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brent Hatzis-schoch owns 2 companies in total, including Black Diamond Therapeutics Inc (BDTX) , and Radius Health Inc (RDUS) .
Click here to see the complete history of Brent Hatzis-schoch’s form 4 insider trades.
Insider Ownership Summary of Brent Hatzis-schoch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BDTX | Black Diamond Therapeutics Inc | 2021-05-12 | See Remarks |
| RDUS | Radius Health Inc | 2017-11-10 | Senior VP and General Counsel |
Brent Hatzis-schoch Latest Holdings Summary
Brent Hatzis-schoch currently owns a total of 2 stocks. Among these stocks, Brent Hatzis-schoch owns 2,278 shares of Radius Health Inc (RDUS) as of November 10, 2017, with a value of $73,967 and a weighting of 73.1%. Brent Hatzis-schoch also owns 8,400 shares of Black Diamond Therapeutics Inc (BDTX) as of May 12, 2021, with a value of $27,216 and a weighting of 26.9%.
Latest Holdings of Brent Hatzis-schoch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RDUS | Radius Health Inc | 2017-11-10 | 2,278 | 32.47 | 73,967 |
| BDTX | Black Diamond Therapeutics Inc | 2021-05-12 | 8,400 | 3.24 | 27,216 |
Holding Weightings of Brent Hatzis-schoch
Brent Hatzis-schoch Form 4 Trading Tracker
According to the SEC Form 4 filings, Brent Hatzis-schoch has made a total of 0 transactions in Radius Health Inc (RDUS) over the past 5 years. The most-recent trade in Radius Health Inc is the acquisition of 1,778 shares on November 10, 2017, which cost Brent Hatzis-schoch around $49,944.
According to the SEC Form 4 filings, Brent Hatzis-schoch has made a total of 10 transactions in Black Diamond Therapeutics Inc (BDTX) over the past 5 years, including 1 buys and 9 sells. The most-recent trade in Black Diamond Therapeutics Inc is the sale of 4,078 shares on May 12, 2021, which brought Brent Hatzis-schoch around $111,819.
Insider Trading History of Brent Hatzis-schoch
- 1
Brent Hatzis-schoch Trading Performance
GuruFocus tracks the stock performance after each of Brent Hatzis-schoch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brent Hatzis-schoch is 7.94%. GuruFocus also compares Brent Hatzis-schoch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brent Hatzis-schoch within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brent Hatzis-schoch's insider trading performs compared to the benchmark.
Performance of Brent Hatzis-schoch
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.3 | | | | | |
| Relative Return to S&P 500(%) | -1.86 | | | | | |
Brent Hatzis-schoch Ownership Network
Ownership Network List of Brent Hatzis-schoch
Ownership Network Relation of Brent Hatzis-schoch
Brent Hatzis-schoch Owned Company Details
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Brent Hatzis-schoch is the See Remarks of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , 10 percent owner Biotech Growth N V , and director & 10 percent owner Ali Behbahani .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Brent Hatzis-schoch made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
Brent Hatzis-schoch Mailing Address
Above is the net worth, insider trading, and ownership report for Brent Hatzis-schoch. You might contact Brent Hatzis-schoch via mailing address: C/o Radius Health, Inc., 950 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
